Summary
First Solar, Inc. reported strong revenue growth in the third quarter of 2017, with net sales increasing by 60% year-over-year to $1.1 billion. This growth was driven by significant project sales and an increase in module volume sold to third parties. Gross profit also saw an improvement, rising by 1.7 percentage points to 26.8%, attributed to a favorable project mix and a reduction in liabilities, despite lower average selling prices for modules. However, module production decreased by 32% as the company transitions to its next-generation Series 6 manufacturing, impacting overall production volume. The company ended the period with a robust cash position of $2.7 billion, an increase from the prior year, supported by project sales and debt financings. Despite significant capital expenditures planned for the Series 6 transition, First Solar believes it has sufficient liquidity for the next 12 months. Management highlighted ongoing competitive pressures in the solar industry, particularly from pricing competition, and the company's strategic focus on cost leadership and utility-scale solar solutions.
Financial Highlights
52 data points| Revenue | $1.09B |
| Cost of Revenue | $795.23M |
| Gross Profit | $291.80M |
| R&D Expenses | $20.85M |
| SG&A Expenses | $50.55M |
| Operating Expenses | $84.81M |
| Operating Income | $206.99M |
| Interest Expense | $4.15M |
| Net Income | $205.75M |
| EPS (Basic) | $1.97 |
| EPS (Diluted) | $1.95 |
| Shares Outstanding (Basic) | 104.43M |
| Shares Outstanding (Diluted) | 105.66M |
Key Highlights
- 1Q3 2017 net sales surged 60% year-over-year to $1.1 billion, driven by project sales and increased module volume.
- 2Gross profit margin improved to 26.8% in Q3 2017, up from 25.1% in Q3 2016, due to project mix and liability adjustments.
- 3Module production decreased by 32% as First Solar shifts towards Series 6 manufacturing, with significant capital investment planned for this transition.
- 4The company maintained a strong liquidity position, with cash, cash equivalents, and marketable securities totaling $2.7 billion as of September 30, 2017.
- 5Research and development expenses decreased by 35% in Q3 2017, reflecting cost-saving measures and program terminations.
- 6Restructuring and asset impairment charges significantly decreased year-over-year, primarily related to the ongoing transition to Series 6 manufacturing.